Allergan reported double-digit sales and earnings growth for the second quarter ended June 30. The diversified health care company reported net earnings of $359.9 million for the quarter, compared with $295.4 million for the second quarter of 2012. Product sales were $1,577.0 million for the quarter, representing a 10.6 percent ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.